ALK1-Fc inhibits multiple mediators of angiogenesis and suppresses tumor growth

Molecular Cancer Therapeutics
Dianne MitchellRavindra Kumar

Abstract

Activin receptor-like kinase-1 (ALK1) is a type I, endothelial cell-specific member of the transforming growth factor-beta superfamily of receptors known to play an essential role in modulating angiogenesis and vessel maintenance. In the present study, we sought to examine the angiogenic and tumorigenic effects mediated upon the inhibition of ALK1 signaling using a soluble chimeric protein (ALK1-Fc). Of 29 transforming growth factor-beta-related ligands screened by surface plasmon resonance, only bone morphogenetic protein (BMP9) and BMP10 displayed high-affinity binding to ALK1-Fc. In cell-based assays, ALK1-Fc inhibited BMP9-mediated Id-1 expression in human umbilical vein endothelial cells and inhibited cord formation by these cells on a Matrigel substrate. In a chick chorioallantoic membrane assay, ALK1-Fc reduced vascular endothelial growth factor-, fibroblast growth factor-, and BMP10-mediated vessel formation. The growth of B16 melanoma explants was also inhibited significantly by ALK1-Fc in this assay. Finally, ALK1-Fc treatment reduced tumor burden in mice receiving orthotopic grafts of MCF7 mammary adenocarcinoma cells. These data show the efficacy of chimeric ALK1-Fc proteins in mitigating vessel formation and suppor...Continue Reading

References

Aug 1, 1997·Developmental Dynamics : an Official Publication of the American Association of Anatomists·B A RoelenC L Mummery
Oct 27, 1999·European Journal of Cell Biology·M Guerrero-EsteoC Bernabéu
Mar 16, 2000·Proceedings of the National Academy of Sciences of the United States of America·S P OhE Li
Apr 6, 2000·American Journal of Medical Genetics·C L ShovlinH Plauchu
Apr 3, 2002·The EMBO Journal·Marie-José GoumansPeter ten Dijke
Dec 25, 2002·Cancer Cell·Olga V VolpertRhoda M Alani
Feb 18, 2003·Human Molecular Genetics·Sudha SrinivasanDouglas A Marchuk
Apr 27, 2005·The Journal of Biological Chemistry·Monica A BrownSenyon Choe
May 10, 2005·Journal of Medical Genetics·S A Abdalla, M Letarte
Apr 15, 2006·Journal of Medical Genetics·C J GallioneD A Marchuk
Apr 11, 2007·Human Molecular Genetics·Africa Fernandez-LLuisa M Botella
Dec 1, 2007·Proceedings of the National Academy of Sciences of the United States of America·Gaorav P GuptaJoan Massagué
Mar 1, 2008·Circulation Research·Laurent DavidSabine Bailly
Apr 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Laleh KamalianYouqiang Ke
Aug 30, 2008·Pathology Oncology Research : POR·Xiaoling YuRongxiang Zhou
Jan 17, 2009·International Journal of Radiation Oncology, Biology, Physics·Marion ScharpfeneckerFiona A Stewart

❮ Previous
Next ❯

Citations

Jun 22, 2012·The Journal of Biological Chemistry·Sharon A TownsonAsya V Grinberg
Feb 13, 2013·The Journal of Experimental Medicine·Charlotte AnderbergKristian Pietras
Jan 25, 2012·Gene Expression·Molly A TaylorWilliam P Schiemann
Dec 21, 2013·Orphanet Journal of Rare Diseases·Anna E HosmanClaire L Shovlin
Jul 3, 2013·Proceedings of the National Academy of Sciences of the United States of America·Hao ChenMinhong Yan
Jun 29, 2011·Cellular and Molecular Life Sciences : CMLS·Marie BidartSabine Bailly
Oct 14, 2010·Molecular Membrane Biology·Sylvia A KuijpersRaymond M Schiffelers
Feb 22, 2012·Expert Opinion on Investigational Drugs·Marco PetrilloGabriella Ferrandina
Sep 24, 2013·Expert Opinion on Investigational Drugs·Lukas Jac HawinkelsPeter Ten Dijke
Nov 1, 2010·Expert Opinion on Drug Discovery·Nicholas C NicolaidesLuigi Grasso
Jun 20, 2012·FEBS Letters·Jie CaiPeter ten Dijke
Oct 16, 2015·Nature Reviews. Cardiology·Nicholas W MorrellKenneth D Bloch
Dec 15, 2015·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Hala H A HazzaaEman A Abo Hager
Jul 27, 2010·Trends in Cell Biology·Evangelia PardaliPeter ten Dijke
Aug 3, 2010·Cytokine & Growth Factor Reviews·Jonathan W Lowery, Mark P de Caestecker
Oct 27, 2015·Pharmacology & Therapeutics·José M Muñoz-FélixJosé M López-Novoa
Jul 14, 2010·Journal of Cellular Biochemistry·Dianne C Mitchell, Brad A Bryan
Oct 4, 2014·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Leon Jonker
Oct 27, 2011·BMB Reports·Meejung Kim, Senyon Choe
Oct 10, 2014·Journal of Cellular and Molecular Medicine·Dongxing ZhuVicky Elizabeth MacRae
May 28, 2013·Biochimica Et Biophysica Acta·María González-NúñezJosé M López-Novoa
Dec 4, 2014·Cytokine & Growth Factor Reviews·Marco Rusnati, Marco Presta
Mar 17, 2012·Developmental Cell·Bruno LarrivéeAnne Eichmann
Nov 18, 2014·Genes & Diseases·Richard N WangLewis L Shi
Feb 25, 2015·Current Oncology Reports·Shilpa GuptaNeeraj Agarwal
Apr 7, 2011·Blood·Sara I Cunha, Kristian Pietras
May 20, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E CaluraC Romualdi
Nov 1, 2016·American Journal of Respiratory and Critical Care Medicine·Beth L Roman, Cynthia St Hilaire
Nov 1, 2016·American Journal of Respiratory and Critical Care Medicine·Lai-Ming YungPaul B Yu
Jul 6, 2014·Human Molecular Genetics·Nicole HellbachTanja Vogel
Nov 18, 2017·PloS One·Laura Ruiz-RemolinaAlicia Rodríguez-Barbero

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.